arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

AIBOTICS, INC.

AIBT
Price unavailable
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
34 Visible periods
20 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Bullish
auto_awesome

Analytical Summary

AIBOTICS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth N/M
Op. Margin None
ROIC 8.4%
FCF / Share
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

34-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
Net Income Profit after all expenses
$-418.11K
↑ +29.3%
Operating Margin Operating profit as % of sales
1.2%
↑ +24.1%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
97
Financial Health
32
Cash Quality
29

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 34 quarters